Disease severity affects the long-term visual outcome of Peter's anomaly.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
What to expect at this year's European Society of Retina Specialists (EURETINA) Congress
Higher Molar Dose and Its Translation into Clinical Practice
European Commission issues CE mark for Zeiss CIRRUS PathFinder AI tool
Green spaces may have "protective effect" against dry eye disease
Starting from scratch on neovascular age-related macular degeneration
Québec announces faricimab (Vabysmo, Roche) will be funded for macular oedema secondary to RVO